Physician profile
Frederick Freitag
NPI 1386636272
$156,937.58
in general payments reported to CMS, 2019-2025
14 companies · $31.65 in 2025
The $31.65 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $31K · 2021: $58K · 2022: $553 · 2023: $50.20 · 2024: $172 · 2025: $31.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $51,678.72 | 2019-2021 | |
| Lilly USA, LLC | $28,614.43 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $19,816.13 | 2019-2022 | |
| Abbvie INC. | $15,286.59 | 2021-2022 | |
| Amgen INC. | $14,421.89 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $12,558.72 | 2020-2021 | |
| Lundbeck LLC | $9,108.01 | 2019-2024 | |
| Biodelivery Sciences International, INC. | $3,000.00 | 2021 | |
| Supernus Pharmaceuticals, INC. | $2,148.26 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $123.57 | 2022 | |
| Impel Pharmaceuticals INC. | $83.02 | 2022-2023 | Trudhesa |
| Pfizer INC. | $66.59 | 2024 | |
| Livanova USA, INC. | $31.65 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Freitag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.